EGFR and neoplasm: Epiregulin (EREG) is a ligand of epidermal growth factor receptor (EGFR), which is involved in RAS-RAF-MAPK and PI3K-AKT-mTOR signaling pathways regulating tumor proliferation, invasion, and migration (51).